Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
CK1 delta inhibition: an emerging strategy to combat neurodegenerative diseases.
Future Med Chem. 2022 Aug;14(15):1111-1113. doi: 10.4155/fmc-2022-0129. Epub 2022 Jul 8.
Future Med Chem. 2022.
PMID: 35801420
No abstract available.
4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives.
Catarzi D, Varano F, Vigiani E, Calenda S, Melani F, Varani K, Vincenzi F, Pasquini S, Mennini N, Nerli G, Dal Ben D, Volpini R, Colotta V.
Catarzi D, et al. Among authors: calenda s.
Pharmaceuticals (Basel). 2022 Apr 14;15(4):478. doi: 10.3390/ph15040478.
Pharmaceuticals (Basel). 2022.
PMID: 35455475
Free PMC article.
Item in Clipboard
Structural Investigations on 2-Amidobenzimidazole Derivatives as New Inhibitors of Protein Kinase CK1 Delta.
Calenda S, Catarzi D, Varano F, Vigiani E, Volpini R, Lambertucci C, Spinaci A, Trevisan L, Grieco I, Federico S, Spalluto G, Novello G, Salmaso V, Moro S, Colotta V.
Calenda S, et al.
Pharmaceuticals (Basel). 2024 Apr 7;17(4):468. doi: 10.3390/ph17040468.
Pharmaceuticals (Basel). 2024.
PMID: 38675428
Free PMC article.
Item in Clipboard
Cite
Cite